CLINICAL_TRIALS
trial_result
· 2022-03-02
Clinical Trial Update: Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata [Phase 2]
Summary
Phase 2 trial evaluating apremilast for acne conglobata reports preliminary efficacy and safety findings.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dr. Frank Behrens | Conditions: Acne Conglobata | Phase 2 | Status: COMPLETED